Posted in | News | Medical Robotics

Argos Therapeutics’ Vice President to Offer Presentation on Automated Arcelis Immunotherapy

Editorial Checklist

Reviewed

Nov 11 2010

Argos Therapeutics has declared that Fred Miesowicz, COO and VP of Manufacturing, will participate in the Cell Therapy Industry Summit-2010, which will be held at the Sheraton Carlsbad Resort and Spa, California and will offer a presentation on the ‘implementation, cost effectiveness and benefits of automation for Argos' Arcelis immunotherapy.’

The company recently proclaimed affirmative interim outcomes of the second phase clinical investigation of the Arcelis immunotherapy, combined with sunitinib, for treating renal cell carcinoma (RCC). It was reported that the company is determined to go ahead t with the phase 3 clinical experiments and execute its automation procedure before commercialization, thereby enabling the company to quickly deal with the medical requirements of the entire targeted RCC patients.

Source:

http://www.argostherapeutics.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback

Public Comment

Private Feedback to AZoRobotics.com

Submit

Robots and Renewable Energy: Hydropower Inspections

Robots and Renewable Energy: Hydropower Inspections

As part of an Editorial short series, AZoRobotics takes a look at how the renewable energy sector is harnessing the power of robotic technologies. Here, we take a look at robots in hydropower stations.

Robots and Renewable Energy: Wind Farm Monitoring

Robots and Renewable Energy: Wind Farm Monitoring

Amid the rapid global expansion of the wind energy sector, the integration of robotics is becoming pivotal for wind farm operators.

Robots and Renewable Energy: Solar Plant Security

Robots and Renewable Energy: Solar Plant Security

Like any renewable energy infrastructure, solar plants must be protected and secured. It is here where robots and autonomous systems can come into play.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.